Study compared real world outcomes of diffuse large b-cell patients treated with Axicabtagene Ciloleucel to the clinical trial.
Home / Resource Library / Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity